iData’s global syringe and needle market MedCore covers both the needle market and the syringe market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

The full report suite on the global market for cardiac rhythm management, electrophysiology & cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the

iData’s global intravascular ultrasound market MedCore covers both the peripheral IVUS market and the coronary IVUS market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

Global TAVI/TAVR, CEPD, and Pre-Shaped Guidewire markets are expected to increase to reach $8.4 billion, $492.3 million, and $70.9 million. The analysis includes in-depth procedure numbers, which will seemingly increase over the forecast period, along with the impact of COVID-19 on the procedure volume.

Globally, over 6 million cardiac surgery procedures were performed in 2020. The majority of these procedures were autotransfusion procedures followed by surgical heart valve procedures. Over the forecast period, all of the procedures included in this report are projected to experience growth, some faster than others, following COVID-19 headwinds. 

In 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026. Throughout this medical market research, we analyzed 43 cardiac surgery companies

In 2020, the European cardiac surgery device market size was valued at €2.6 billion, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market size is expected to reach an insane €5.6 billion in 2026. Throughout this medical market research, we analyzed 40 cardiac surgery companies across 15 countries in Europe

The full report suite on the global market for cardiac ablation catheters includes radiofrequency (RF) ablation catheters and cryoablation catheters.

The full report suite on the global market for cardiac resynchronization therapy (CRT) devices includes cardiac resynchronization therapy-pacemakers (CRT-Ps) and cardiac resynchronization therapy-defibrillators (CRT-Ds).

The full report suite on the global market for diagnostic electrophysiology (EP) catheters includes conventional electrophysiology catheters, advanced electrophysiology catheters and intracardiac echocardiography (ICE) catheters.

The full report suite on the global market for electrophysiology (EP) lab system includes 3D mapping systems and electrophysiology (EP) recording systems.

The full report suite on the global market for cardiac resynchronization therapy (CRT) devices includes cardiac resynchronization therapy-pacemakers (CRT-Ps) and cardiac resynchronization therapy-defibrillators (CRT-Ds).

Overall, the global implantable loop recorder market was valued at over $1.3 billion in 2021. This is expected to increase over the forecast period at a CAGR of 7.9% to reach nearly $2.3 billion.

The full report suite on the global market for pacemakers includes single-chamber pacemakers, dual-chamber pacemakers and leadless pacemakers.